Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) [Phase 3]

View source ↗

Summary

Phase 3 trial ICONIC-ADVANCE 2 evaluating JNJ-77242113 for moderate-to-severe plaque psoriasis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING